Class information for:
Level 1: PRIMARY VENTRICULAR FIBRILLATION//CARDIOMETABOL PHYSIOPATHOL PHARMACOL//GISSI COORDINATING

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
21882 345 26.6 62%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
213 20130 ATRIAL FIBRILLATION//PULMONARY VEIN ISOLATION//CATHETER ABLATION

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 PRIMARY VENTRICULAR FIBRILLATION Author keyword 4 67% 1% 4
2 CARDIOMETABOL PHYSIOPATHOL PHARMACOL Address 2 67% 1% 2
3 GISSI COORDINATING Address 2 50% 1% 3
4 NEW ONSET ATRIAL FIBRILLATION Author keyword 2 40% 1% 4
5 ACUTE CORONARY FAILURE Author keyword 1 50% 0% 1
6 GULF RACE 2 Author keyword 1 50% 0% 1
7 HOSP UNIV MED QUIRURG Address 1 50% 0% 1
8 IKATP Author keyword 1 50% 0% 1
9 LIDOCAINE PLASMA LEVELS Author keyword 1 50% 0% 1
10 MAYO CLIN LIB SYST Address 1 50% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 PRIMARY VENTRICULAR FIBRILLATION 4 67% 1% 4 Search PRIMARY+VENTRICULAR+FIBRILLATION Search PRIMARY+VENTRICULAR+FIBRILLATION
2 NEW ONSET ATRIAL FIBRILLATION 2 40% 1% 4 Search NEW+ONSET+ATRIAL+FIBRILLATION Search NEW+ONSET+ATRIAL+FIBRILLATION
3 ACUTE CORONARY FAILURE 1 50% 0% 1 Search ACUTE+CORONARY+FAILURE Search ACUTE+CORONARY+FAILURE
4 GULF RACE 2 1 50% 0% 1 Search GULF+RACE+2 Search GULF+RACE+2
5 IKATP 1 50% 0% 1 Search IKATP Search IKATP
6 LIDOCAINE PLASMA LEVELS 1 50% 0% 1 Search LIDOCAINE+PLASMA+LEVELS Search LIDOCAINE+PLASMA+LEVELS
7 PROSPECTIVE RANDOMIZED ENDPOINT TRIAL 1 50% 0% 1 Search PROSPECTIVE+RANDOMIZED+ENDPOINT+TRIAL Search PROSPECTIVE+RANDOMIZED+ENDPOINT+TRIAL
8 SECONDARY VENTRICULAR FIBRILLATION 1 50% 0% 1 Search SECONDARY+VENTRICULAR+FIBRILLATION Search SECONDARY+VENTRICULAR+FIBRILLATION
9 NOVEL ANTIPLATELET AGENTS 0 33% 0% 1 Search NOVEL+ANTIPLATELET+AGENTS Search NOVEL+ANTIPLATELET+AGENTS
10 SYSTEMIC ACIDOSIS 0 33% 0% 1 Search SYSTEMIC+ACIDOSIS Search SYSTEMIC+ACIDOSIS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 GUSTO III EXPERIENCE 18 89% 2% 8
2 PRIMARY VENTRICULAR FIBRILLATION 12 59% 4% 13
3 PREHOSPITAL PHASE 1 33% 1% 2
4 1ST 12 HOURS 1 50% 0% 1
5 INTRAMUSCULAR LIDOCAINE 1 50% 0% 1
6 ISIS 4 1 50% 0% 1
7 PROPHYLACTIC LIDOCAINE 1 17% 1% 3
8 TIMI FLOW 0 33% 0% 1
9 TOLERANCE DATA 0 33% 0% 1
10 HIGHLY PURIFIED OMEGA 3 FATTY ACIDS 0 25% 0% 1

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Mortality Associated With Atrial Fibrillation in Patients With Myocardial Infarction A Systematic Review and Meta-Analysis 2011 55 42 67%
Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications 2009 96 53 40%
Risk factors for primary ventricular fibrillation during acute myocardial infarction: a systematic review and meta-analysis 2006 33 42 43%
EFFECTS OF PROPHYLACTIC LIDOCAINE IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - AN OVERVIEW OF RESULTS FROM THE RANDOMIZED, CONTROLLED TRIALS 1988 171 10 50%
Mechanisms of new-onset atrial fibrillation complicating acute coronary syndrome 2015 0 68 51%
Temporal Evolution and Implications of Ventricular Arrhythmias Associated With Acute Myocardial Infarction 2013 1 43 33%
Prophylactic lidocaine for myocardial infarction 2015 0 89 33%
Can We Predict Outcomes in Atrial Fibrillation? 2012 0 35 26%
LIDOCAINE IN THE EARLY PHASE OF ACUTE MYOCARDIAL-INFARCTION - THE CONTROVERSY OVER PROPHYLACTIC OR SELECTIVE USE 1990 7 15 60%
RAPID PREDICTION OF INDIVIDUAL DOSAGE REQUIREMENTS FOR LIGNOCAINE 1984 26 13 38%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 CARDIOMETABOL PHYSIOPATHOL PHARMACOL 2 67% 0.6% 2
2 GISSI COORDINATING 2 50% 0.9% 3
3 HOSP UNIV MED QUIRURG 1 50% 0.3% 1
4 MAYO CLIN LIB SYST 1 50% 0.3% 1
5 ST MARIEN HOSP LUNEN 1 50% 0.3% 1
6 MED GEN INTERNAL MED SECT 0 33% 0.3% 1
7 AUSL 2 0 25% 0.3% 1
8 KARDIOL KLIN 1 0 25% 0.3% 1
9 CARDIOLHOSP 2 0 20% 0.3% 1
10 NONINVAS S 0 20% 0.3% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000094832 NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME//TERRENCE DONNELLY HEART//CANADIAN HEART
2 0.0000089513 ANIPAMIL//KINGS CARDIOVASC BIOL MED//S 2150
3 0.0000085751 ATRIAL FIBRILLATION//WARFARIN//CITY HOSP
4 0.0000082930 PROGRAMMED VENTRICULAR STIMULATION//ENCAINIDE//PROGRAMMED STIMULATION
5 0.0000082741 ATRIAL REMODELING//ELECTRICAL REMODELING//SUPRAVENTR ARRHYTHMIA
6 0.0000075984 LEFT BUNDLE BRANCH BLOCK//BUNDLE BRANCH BLOCK//RIGHT BUNDLE BRANCH BLOCK
7 0.0000075460 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR//IMPLANTABLE CARDIOVERTER DEFIBRILLATORS//ICD
8 0.0000072940 COLLATERAL CORONARY FLOW//ADV MED TRAINING STATE//BETA BLOCKER
9 0.0000069791 NON Q WAVE MI//NON Q MYOCARDIAL INFARCTION//NON Q WAVE
10 0.0000067583 P WAVE DISPERSION//P WAVE DURATION//INTERATRIAL BLOCK